A Case of Idiopathic Intracranial Hypertension Treated by Transverse Sinus Stenting.
intracranial hypertension
papilledema
stenting
transverse sinus
Journal
Journal of neuroendovascular therapy
ISSN: 2186-2494
Titre abrégé: J Neuroendovasc Ther
Pays: Japan
ID NLM: 101488164
Informations de publication
Date de publication:
2021
2021
Historique:
received:
18
07
2020
accepted:
20
12
2020
medline:
1
1
2021
pubmed:
1
1
2021
entrez:
28
7
2023
Statut:
ppublish
Résumé
We report a patient with chronic headache due to idiopathic intracranial hypertension (IIH) associated with transverse sinus (TS) stenosis. The symptom improved after stent placement at the site of stenosis. The patient was a 37-year-old woman with progressive headache and diplopia as chief complaints. She had severe bilateral papilledema. Magnetic resonance imaging (MRI) and angiography revealed stenosis of the bilateral TS. Lumbar puncture demonstrated raised intracranial pressure and IIH was tentatively diagnosed. Visual impairment progressed despite oral acetazolamide therapy. A venous pressure gradient was monitored during stent placement. The pressure gradient improved after stenting. Dual antiplatelet therapy was initiated 1 week before the procedure. Papilledema and headache resolved immediately after the procedure. No in-stent stenosis or occlusion occurred during the follow-up period. Stent placement for TS stenosis can improve the cerebral venous return in IIH patients. Although restenosis is possible, venous sinus stenting is considered an effective treatment.
Identifiants
pubmed: 37502372
doi: 10.5797/jnet.cr.2020-0145
pii: jnet.cr.2020-0145
pmc: PMC10370568
doi:
Types de publication
Case Reports
Langues
eng
Pagination
653-658Informations de copyright
©2021 The Japanese Society for Neuroendovascular Therapy.
Déclaration de conflit d'intérêts
The authors completed self-reporting of conflicts of interest (COI) to the Japanese Society of Internal Medicine and Japan Neurosurgical Society. The authors declare no conflicts of interest regarding the publication of this article.
Références
World Neurosurg. 2011 May-Jun;75(5-6):648-52; discussion 592-5
pubmed: 21704931
Neurointervention. 2018 Sep;13(2):138-143
pubmed: 30196687
Neurology. 2013 Sep 24;81(13):1159-65
pubmed: 23966248
J Neurosurg. 2003 May;98(5):1045-55
pubmed: 12744365
Lancet Neurol. 2016 Jan;15(1):78-91
pubmed: 26700907
Neurology. 2003 May 13;60(9):1418-24
pubmed: 12743224
Neurology. 2002 Nov 26;59(10):1492-5
pubmed: 12455560
JCI Insight. 2019 Mar 21;4(6):
pubmed: 30753168
AJNR Am J Neuroradiol. 2011 Sep;32(8):1408-14
pubmed: 21799038
J Neuroophthalmol. 2013 Jun;33(2):117-22
pubmed: 23502837
AJNR Am J Neuroradiol. 2015 Oct;36(10):1899-904
pubmed: 26251432
J Neurosurg. 2012 Mar;116(3):538-48
pubmed: 22149379
AJNR Am J Neuroradiol. 2010 Apr;31(4):645-50
pubmed: 19942702
Neurology. 2008 Feb 19;70(8):641-7
pubmed: 18285539
J Neurointerv Surg. 2013 Jan 1;5(1):62-8
pubmed: 22146571
World Neurosurg. 2016 Dec;96:611.e15-611.e18
pubmed: 27633717
J Neurol Neurosurg Psychiatry. 2003 Dec;74(12):1662-6
pubmed: 14638886